Ftse Mib
33.218,53
-0,03%
DAX
19.074,23
0,38%
S&P 500
5.917,11
0,00%
NASDAQ
18.966,14
0,00%
Bitcoin
97.641,03
3,48%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Anavex Life Sciences Corporation (AVXL) Anavex Life Sciences Corporation (AVXL) Notizie

Anavex Life Sciences Corporation

AVXL
8,475
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 13:38:34
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
31/10/202409:00GLOBEAnavex’s Blarcamesine Achieves Pre-specified Efficacy in..
23/10/202414:03IHNWZenaTech, Inc. (NASDAQ: ZENA) Software Company Acquisition
17/10/202413:30GLOBEAnavex Life Sciences Announces Encouraging Preliminary..
15/10/202414:21IHNWZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano..
01/10/202413:00IHNWZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today
03/9/202413:30GLOBEAnavex Life Sciences to Present at the H.C. Wainwright 26th..
06/8/202423:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202413:30GLOBEAnavex Life Sciences Reports Fiscal 2024 Third Quarter..
01/8/202413:30GLOBEAnavex Life Sciences to Announce Fiscal 2024 Third Quarter..
30/7/202423:20EDGAR2Form 8-K - Current report
30/7/202413:30GLOBEAnavex Life Sciences Announces Translational Biomarker Data..
29/7/202423:21EDGAR2Form S-3 - Registration statement under Securities Act of..
28/7/202423:00GLOBEResults from Anavex Life Sciences Landmark Phase IIb/III..
20/6/202413:30GLOBEAnavex Life Sciences to Present at the H.C. Wainwright..
17/6/202413:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202413:30GLOBEAnavex Life Sciences Announces Expansion of Leadership Team
17/5/202412:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202413:30GLOBEAnavex Life Sciences to Present at the H.C. Wainwright 2nd..
10/5/202411:45PRNUSShareholders that lost money on Anavex Life Sciences..
09/5/202422:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202414:00EDGAR2Form 8-K - Current report
09/5/202413:30GLOBEAnavex Life Sciences Reports Fiscal 2024 Second Quarter..
07/5/202411:45PRNUSThe Gross Law Firm Announces the Filing of a Securities..
06/5/202412:03EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
03/5/202411:45PRNUSAnavex Life Sciences Corporation Sued for Securities Law..
02/5/202413:30GLOBEAnavex Life Sciences to Announce Fiscal 2024 Second Quarter..
26/4/202411:45PRNUSMay 13, 2024 Deadline: Contact The Gross Law Firm to Join..
19/4/202411:45PRNUSContact The Gross Law Firm by May 13, 2024 Deadline to Join..
16/4/202411:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
12/4/202411:45PRNUSClass Action Filed Against Anavex Life Sciences Corporation..
11/4/202413:30GLOBEAnavex Life Sciences to Present at the Noble Capital Markets..
09/4/202411:45PRNUSClass Action Filed Against Anavex Life Sciences Corporation..
05/4/202411:45PRNUSAnavex Life Sciences Corporation Class Action: The Gross Law..
02/4/202411:45PRNUSShareholders that lost money on Anavex Life Sciences..
29/3/202410:45PRNUSLost Money on Anavex Life Sciences Corporation(AVXL)? Join..
26/3/202410:45PRNUSInvestors who lost money on Anavex Life Sciences..
25/3/202412:30GLOBEAnavex Life Sciences to Present at the 23rd Annual Needham..
22/3/202410:45PRNUSAVXL LAWSUIT ALERT: The Gross Law Firm Notifies Anavex Life..
18/3/202412:30GLOBEAnavex Life Sciences Initiates Placebo-Controlled U.S. Phase..
26/2/202413:30GLOBEAnavex Life Sciences to Present at the 44th Annual TD Cowen..
23/2/202412:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202412:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202412:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202412:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202412:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/2/202413:30GLOBEAnavex Life Sciences Reports Fiscal 2024 First Quarter..
01/2/202413:30GLOBEAnavex Life Sciences to Announce Fiscal 2024 First Quarter..
25/1/202423:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/1/202413:30GLOBEAnavex Life Sciences Reports Publication of ANAVEX®3-71 in..
Apertura: Min: Max:
Chiusura: 8,475

La tua Cronologia

NASDAQ
AVXL
Anavex Life Sciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network